The one year survival rate in group A(16.7%) was lower than that in group B(40.0%) . Conclusion The general SCLC chemotherapy regimen is suitable for NSCLC patients with high serum NSE level.

 
  • 1年生存率40.;0%25;两组差异有显著(P<0
今日热词
目录 附录 查词历史